SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.05 Cr | ₹-0.16 Cr | ₹0.37 Cr | ₹0.06 Cr | ₹-0.05 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SAKAR HEALTHCARE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-0.05 Cr |
| Mar2025 | ₹-0.16 Cr |
| Mar2024 | ₹0.37 Cr |
| Mar2023 | ₹0.06 Cr |
| Mar2022 | ₹-0.05 Cr |
How is Net Cash Inflow / Outflow of SAKAR HEALTHCARE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-0.05 Cr | Negative | |
| Mar2025 | ₹-0.16 Cr | Negative | |
| Mar2024 | ₹0.37 Cr | 481.25 | |
| Mar2023 | ₹0.06 Cr | Positive | |
| Mar2022 | ₹-0.05 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,229.4 Cr | 6.3% | 0.2% | 162.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 6.3% |
0.2% |
162.2% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses